Momelotinib: an emerging treatment for myelofibrosis patients with anemia

Overview of attention for article published in Journal of Hematology & Oncology, January 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#18 of 1,309)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 32 news stories from 21 outlets.

GSK Logo (CNW Group/GlaxoSmithKline Inc.) Share on FacebookShare on TwitterShare on Whatsapp Health Canada’s acceptance of the…

Health Canada's acceptance of the submission follows that of the Ministry of Health, Labour and Welfare (WHLW) in and approval…

Classé dans : Santé L'acceptation de cette présentation par Santé Canada fera suite à celle du ministère de la Santé, du…

Classified in: Health Health Canada's acceptance of the submission follows that of the Ministry of Health, Labour and Welfare (WH…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 28 additional news stories.